Inactive Instrument

Cornerstone Therapeutics, Inc. Share Price

Stocks

End-of-day quote Nasdaq Other stock markets
- ^USD	-

28/02/14	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Inc. Stockholders Approve Merger	PU
03/02/14	Cornerstone Therapeutics Inc. Stockholders Approve Merger	MW
31/01/14	Cornerstone Therapeutics Adjourns Special Meeting of Stockholders	MW
20/11/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics Launches BETHKIS(R) (Tobramycin Inhalation Solution) for Management of Cystic Fibrosis Patients With Pseudomonas Aeruginosa	PU
31/10/13	Cornerstone Therapeutics, Inc. : Cornerstone Therapeutics to Host Third Quarter 2013 Conference Call	PU

16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)
16/09/13	USA-Les valeurs à suivre à Wall Street (actualisé)

Manager	Title	Age	Since
Jon Zwinski CEO	Chief Executive Officer	-	31/12/2020
William James Alexander CTO	Chief Tech/Sci/R&D Officer	76	-

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0.66%	+0.44%	+14.72%	+76.40%	48.41B
OTSUKA HOLDINGS CO., LTD.	+2.20%	+1.18%	+62.94%	+112.48%	34.99B
CIPLA LIMITED	+1.26%	-0.57%	-5.20%	+34.48%	11.62B
ZYDUS LIFESCIENCES LIMITED	-0.46%	-3.06%	+14.15%	+80.63%	11.47B
KRKA, D. D.	-1.12%	-0.19%	+36.83%	+136.73%	8.99B
ONO PHARMACEUTICAL CO., LTD.	+1.52%	+3.77%	+49.89%	-4.79%	6.88B
GEDEON RICHTER	-0.09%	-2.84%	+13.23%	+30.57%	6.62B
GLENMARK PHARMACEUTICALS LIMITED	-0.59%	-1.95%	+2.23%	+178.07%	6.43B
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	+1.60%	-15.49%	-29.66%	+8.47%	5.75B
Average	+0.41%	-1.88%	+17.68%	+72.56%	15.69B
Weighted average by Cap.	+0.42%	-1.08%	+25.66%	+81.83%

Employees

Sector